Company / Accounts Receivable
Personalis, Inc. Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$16.2M
FY2025
5-year range
$16.2M / $18.5M
FY2021-FY2025
Trend
-8.6%
vs FY2024
Sector context
#130 of 138
Health Care
What the data says
Among 138 Health Care companies, Personalis, Inc. is in the bottom 6% for accounts receivable. Accounts Receivable has fluctuated over the past 8 years, ranging from $3M in FY2019 to $18M in FY2021.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +20.6%.
Declined from $17M to $16M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- +20.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 138This company $16.2M Sector average $1.3B
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.6%, indicating consistent growth.
- In FY2025, accounts receivable decreased 8.6% year-over-year.
- Ranks #130 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.2M | -8.6% |
| FY2024 | $17.7M | +6.5% |
| FY2023 | $16.6M | +0.0% |
| FY2022 | $16.6M | -9.9% |
| FY2021 | $18.5M | +190.9% |
| FY2020 | $6.3M | +92.4% |
| FY2019 | $3.3M | -26.0% |
| FY2018 | $4.5M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026